SCHEMBL14978738

SCHEMBL14978738

CC(=O)Nc1ccc(BOC(C)(C)C(C)(C)O)cn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTK2 Q05397 1/20 0.48
CYP1A2 P05177 1/20 0.43
GAA P10253 1/20 0.43
KDM4E B2RXH2 1/20 0.39
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
KMT2A Q03164 1/20 0.39
MET P08581 1/20 0.38
NSD2 O96028 1/20 0.37
RAB9A P51151 2/20 0.36
MAPT P10636 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CDK8 P49336 1/20 0.35
DEGS1 O15121 1/20 0.35
NPC1 O15118 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TDO2 P48775 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
MAPK8 P45983 1/20 0.34
EGFR P00533 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27005881 0.85 BCL2 (0.41) RAB9AMAPTDEGS1
SCHEMBL24444990 0.82 HCAR3 (0.39) MAPTTDO2
SCHEMBL15785516 0.80
SCHEMBL15079563 0.77 L3MBTL1 (0.40) PTK2CYP1A2GAARAB9AL3MBTL1
SCHEMBL22084822 0.76
SCHEMBL7876853 0.76 KMT2A (0.37) KMT2A
SCHEMBL19418256 0.76 KMT2A (0.42) KDM4EKMT2AL3MBTL1
SCHEMBL8064319 0.76 MAPK1 (0.50) CYP1A2KDM4EKMT2AMAPTL3MBTL1
SCHEMBL23341275 0.75 PIP5K1C (0.40) CYP1A2KDM4ERAB9AMAPTNPC1
SCHEMBL8065893 0.75 KDM4E (0.37) KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2719697-B1 PYRIDONAPHTHYRIDINE PI3K/MTOR DUAL INHIBITORS AND PREPARATION AND USE THEREOF XUANZHU PHARMA CO LTD (CN) 2018-08-01 EP disclosed
WO-2013071698-A1 THREE-RING PI3K AND/OR MTOR INHIBITOR 山东轩竹医药科技有限公司 (CN) 2013-05-23 WO disclosed